Answer
Tumour lysis syndrome was observed most frequently during the first month of mogamulizumab treatment.
Sources for this answer
- Poteligeo 4 mg/mL, Concentrate for Solution for InfusionKyowa Kirin Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 8Document updated
Sources checked